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This review found that chlorpyrifos exposure may be associated with negative impacts on 
the gut microbiome, especially obesity, diabetes, and compromised immune response. Perinatal 
exposure in rats was also linked to dysbiosis of intestinal microbes. Further research resulting in 
primary data would be needed to substantiate the relationships. Even with a clear understanding 
of the relationship, further research needs to be conducted to determine if the microbes are a 
product of health outcomes or vice versa. Species-level investigation would be critical in 
characterizing the true interactions of the gut. This information can be used to identify another 
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This thesis will explore the effects of chlorpyrifos exposure through fruit and vegetable 
consumption on the gut microbiome and the implicit health effects. The growing risk of climate 
change has pressured society to evaluate the carbon footprint of the existing food system, 
discover the high resource demands and emissions from meat production, and thus motivated a 
push for plant-based diets (Schiermeier 2019). As more people buy into these diets, it is 
important to consider the nuances in the nutritional profile of fruits and vegetables people will 
have access to. There is evidence that residue from organophosphorus pesticides is still present 
on the produce (in these studies: cucumber, apples, cabbage, eggplant, tomato, cucumber, garlic 
sprouts) sold at supermarkets and is subsequently consumed if not foods are not washed and 
cooked thoroughly (Liang et al., 2012, Xiao et al., 2015, Ling et al., 2011). “Round-Up Ready” 
genetically modified soybeans, which are resistant to herbicides, have been found to contain high 
residues of glyphosate, the most commonly used pesticide from 2008-2012 (Bohn et al., 2013, 
EPA 2012). Organic produce is advertised as a means of avoiding pesticide exposure and a study 
found it to be associated with significantly reduced exposure to pesticide metabolites (Bradman 
2015).  Even if this proves to be true, there may be health implications for low-income 
populations that cannot afford the premium of organic fruits and vegetables. This systematic 
review aims to investigate a few of the possible health outcomes. 
It has been known for a long time that the gut microbiome plays a vital role in human 
health, but the unknown still outnumbers the known. In general, bacteria, archaea, fungi, and 
viruses all make up the gut ecosystem (Belizario 2018). These microorganisms play a role in 
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digestion, nutrient absorption, and have recently been discovered to be involved in brain activity 
that will be discussed further in the following sections. Some gut microbes may have co-evolved 
with hosts to degrade otherwise toxic substances that have been ingested (Mesnage 2018). This 
dynamic ecosystem of living organisms is also prone to change when foreign substances are 
introduced and detrimental changes are referred to as dysbiosis. Belizario et al. define dysbiosis 
generally as an “imbalance of gut’s microbial community” (Belizario 2018).  
 
Chlorpyrifos Uses and Impacts on Health 
Chlorpyrifos is a colorless, though sometimes crystalline, diethylphosphorothionate 
organophosphate with a distinct, yet faint, odor that is applied most commonly in agriculture as 
an insecticide and herbicide (PubChem). In pests, it acts as a neurotransmitter inhibitor, 
specifically targeting acetylcholine, by binding to the enzyme cholinesterase until the high 
accumulation of acetylcholine becomes toxic and kills the neuronal cells (EPA 2012). 
According to the Environmental Protection Agency (EPA)’s ​Pesticides Industry Sales and Usage 
2008-2012 report, Chlorpyrifos is the 14th most commonly used pesticide in the United States of 
America in 2012 (EPA 2012). It is applied to crops such as fruits, vegetables (especially corn), 
nut trees, grain crops and although not soluble in water, it can be detected in urine and blood 
samples if ingested (EPA 2016, PubChem, Li et al., 2019).   Diethylphosphate (DEP), 
diethylthiophosphate (DETP) and 3,5,6-trichloro-2-pyridinol (TCPy) are three known 
metabolites of chlorpyrifos that can also be found in urine samples and thus often serve as 
biomarkers. In a human study (n=5) where volunteers ingested 1 mg of chlorpyrifos, Griffin et 
al. found that nearly the entire oral dose of the pesticide would be excreted in through urine in 
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the form of metabolites (Griffin et al., 1999). Another study with male human volunteers found 
that chlorpyrifos had a 27-hour half-life with 70% of the dose present in their urine (Wagner et 
al., 1999). In male rats, 83-87% of a 19 mg/kg body weight dose of chlorpyrifos was present in 
urine and feces after 72 hours (Wagner et al., 1999). 
Agency sponsored studies have found increased odds of neurological effects, such as 
mental delay and attention disorders , in children who were exposed to chlorpyrifos (EPA 2016). 
Rat studies by Peris-Sampedro et al. found that chlorpyrifos exposure was associated with 
increased body weight and impaired memory while Joly Condette et al. observed bacterial 
translocation from increased gut permeability with exposure to the pesticide (Peris-Sampedro et 
al., 2015, Joly Condette et al.,  2014). Organophosphates, in general, have been found to affect 
the gut-brain axis, which will be defined in the next section (Roman et al. 2019). High 
concentrations of chlorpyrifos in the body have also been linked to lung cancer and autoimmune 
disorders (PubChem).  
 
Gut Microbes’ Roles in Neurological Function and Mental Health 
Gut microbes may impact neurological functions and mental health through an important 
biochemical pathway called the gut-brain axis. As the name suggests, this connection links the 
gastrointestinal tract and the central nervous system, allowing for bidirectional communication 
between the two; therefore dysbiosis can result in central nervous and gastrointestinal disorders 
(Carabotti et al., 2015). Some microbes produce and are even able to receive, neurotransmitters, 
which can also be used to signal immune responses (Fung et al., 2017). Dempsey et al., found 
that the metabolites from these microbes can alter the expression of central nervous 
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system-related genes in the host via systemic circulation, influencing neuroinflammation and cell 
death (Dempsey et al., 2019). Enteroendocrine cells have also been found to be involved in the 
relay of sensory information from the gut, suggesting that there may be an influence on emotions 
as well as eating disorders through the interactions between gut microbes and hormones (Mayer 
2011). Researchers have investigated the gut microbe profile of people with existing 
neurological conditions in an effort to understand possible links. A study of a Han Chinese 
population diagnosed with sporadic Parkinson’s Disease, a neurodegenerative disorder, had 
higher number of microbes in the following phyla:  Lachnospiracea, Hydrogenoanaerobacterium, 
Porphyromondaceae, Ruminococcaceae,  and Verrucomicrobiaceae (Li et al., 2019). 
Akkermansia muciniphila​ (from phylum Verrucomicrobiaceae) in particular has been found to be 
positively associated with Parkinson’s Disease, multiple sclerosis in  multiple studies, and autism 
spectrum disorder (Jangi et al., 2016, Fang et al., 2019).  
 
Gut Microbes’ Roles in Obesity and Diabetes 
Microbe produced short-chain fatty acids (SCFA) such as propionate and butyrate play a 
role in metabolism and inducing intestinal gluconeogenesis (De Vadder 2014). ​Chiu et al. 
compiled metadata from cross-sectional studies of Taiwanese individuals’ gut microbes and 
corresponding body mass index (BMI) and found the following microbial profile (at the genus 
level) of people with a BMI of 24: ​Bacteroides​ (27.7%),​ Prevotella​ (19.4%),​ Escherichia​ (12%), 
Phascolarctobacterium​ (3.9%), and​ Eubacterium​ (3.5%) (Chiu et al., 2014). People with a BMI 
of 27 had the following profile:​ Bacteroides​ (29%),​ Prevotella​ (21%),​ Escherichia​ (7.4%), 
Megamonas​ (5.1%), and​ Phascolarctobacterium​ (3.8%) (Chiu et al., 2014). A comparative 
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analysis of various prospective double-blind placebo studies involving human participants found 
that the ​Lactobacillus​ genus has species ​L. gasseri​ and ​L. plantarum​ have observed protective 
effects against obesity through food supplements while  ​L. acidophilus​, ​L. ingluviei​ and ​L. 
fermentum​ were associated with weight gain (Million et al., 2012). Broadly, several health 
outcomes, including obesity, seem to be a correlation with the ratio of phyla Firmacutes to 
Bacteroidetes. Yan et al. found obese rats had significantly more abundant Firmicutes and less 
Bacteroidetes relative to lean rats (Yan et al., 2016).  
The characteristics of microbes and their interactions, associated with obesity are similar 
to those associated with diabetes as they are both metabolism-based conditions. In terms of 
diabetes, microbes have been linked to low-grade inflammatory responses for cases of type 2 
diabetes and insulin resistance (Everand et al., 2013). Everand et al. were able to identify 
lipopolysaccharide derived from microbiota as a potential key player in the mechanism of 
metabolic disease. It is also suspected that butyrate may play an important role in metabolism, 
thus those bacteria that are able to produce this SCFA would prove to be beneficial against 
diabetes (Qin et al., 2012).  
 
Gut Microbes’ Roles in Other Functions 
Most obviously, gut microbes play a critical role in gastrointestinal health. At the genus 
level, ​Lactobacillus​, ​Allobaculum​, ​Candidatus Arthromitus​, and at the family level ​Rikenellaceae 
have been positively correlated with ileal immune response when pathogens are introduced(Cox 
et al., 2014). A relatively higher Firmicute:Bacteroidetes ratio has also been ​associated with 
inflammatory bowel disease (Rajilic-Stojanovic et al., 2011). Crohn’s disease is a specific 
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inflammatory bowel disease that is associated with uncharacterized dysbiosis and relatively 
lower microbiota diversity (Joossens et al., 2011). 
 
Chlorpyrifos Exposure and Microbiota Analysis Methods 
Per the acquisition criteria, all the studies administered the chlorpyrifos orally. The 
dosages for their test group ranged from 0.3 mg/kg body weight to 5 mg/kg body weight through 
an oil vehicle (usually corn oil) while the control groups were not given any. The test animals 
received doses daily ranging of 21 days to 12 weeks. All of the studies examined in this review 
were conducted on animals: rats and mice. Generally, 16S rRNA gene analysis was conducted on 
fecal samples extracted from the animals after they were orally administered a set concentration 
of chlorpyrifos. Fang et al., quantified the DNA by ultraviolet spectroscopy and sequenced (Fang 
et al., 2018, Wang et al., 2019). Teams like Joly Condette et al., conducted species-specific 
quantitative reverse transcription PCR from fecal samples as well as also extracted relevant 
organs to measure anaerobic microbe cultures (Joly Condette, et al., 2015, Perez-Fernandez et 
al., 2020).  
METHODS 
Searches were conducted using Google Scholar and PubMed. Searches included a 
combination of the following terms: chlorpyrifos, pesticide, organophosphate, gut, microbiome, 
microbiota, health. Significant health outcomes were identified upon initial investigation and the 
following terms were added to the search: obesity, diabetes, mental health, brain axis, immune 
system, digestion, Parkinson’s disease, autism, chronic fatigue, depression, multiple sclerosis, 
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multiple system atrophy. The selection criteria for the studies relating to chlorpyrifos and health 
are the following: 
● Must specifically include chronic, oral chlorpyrifos exposure with any level of 
exposure 
● Any stage of life 
● Microbial profile must be at Phylum level at minimum 
● Test Subjects: rats and mice 
 
To understand the possible risk of regularly consuming produce that is potentially contaminated, 
it is important that the studies investigate the effects of chronic exposure. Although pesticide 
exposures through produce consumption are likely small, having a variation in dosage will 
provide a broader understanding of diverse eating patterns. Considering that produce 
consumption is recommended for people of all ages,  the review will not discriminate by stages 
of life.  
RESULTS 
Selected Studies 
Ten studies were chosen and summarized in Table 1.  Three included a diet component, 
comparing chlorpyrifos exposure impacts between animals receiving normal-fat and high-fat 
diets, which allowed them to understand how exposure to this pesticide and possible interactions 
with fat intake had impacted the gut microbiome. Fang et al. found that mice receiving 
normal-fat diets and low dosages of chlorpyrifos were more likely to be associated with 
12 
 
pro-obesity phenotypes and reduced serum insulin, while Li et al. found that high-fat diets 
stunted the negative impacts of chlorpyrifos (Fang et al., 2018, Li et al., 2019).  Four studies 
included perinatal exposure;  one of which, Guardia-Escote et al., only investigated postnatal 
exposure.  
 
Table 1 Selected Studies 
Study Type Animal Exposure 
Fang et al., 2018 Dose and Diet Rats, Adult Daily, 0.3 mg/kg(l) 3 mg/kg(h), 9 Weeks 
Guardia-Escote et al., 2019 Dose Mice, Postnatal 
Daily, 1 mg/kg in 1 microgram/g body 
weight, 5 days postnatal 
Joly et al., 2013 Dose Rats, Adult and Pup 
Daily, 1 mg/kg body weight, 30 days; 
pregnant: 1 mg/kg body weight until 
weaned 
Joly Condette et al., 2015 Dose Rats, Adult and Pup 
Daily, Adult female: 1 or 5 mg/kg body 
weight from gestation onset up to weaning; 
Pups received the same 
Li et al., 2019 Dose and Diet 
Rats, Pup (3 weeks) 
and Adult (8 weeks) 
daily, 0.3 mg/kg for 25 weeks (baby) 20 
weeks (adult) 
Liang et al., 2019 Dose and Diet Mice, Adult daily, 5mg/kg for 12 weeks 
Reygner et al., 2016 Dose, Insulin Rats, Pup 
daily, 1 mg/kg/day (CPF1) or 3.5 mg/kg/day 
(CPF3.5), 21 days 
Zhao et al., 2016 Dose Mice, Adult daily, 1 mg/kg, 30 days 
 
Observed Changes in Gut Microbiota from Chlorpyrifos Exposure 
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The literature review found that there were four genuses of microbes that were most 
studied: ​Bacteriodes, Bifidobacterium, Firmicutes, ​and ​Lactobacillus​. The results, summarized in 
Table 4 in the Appendix, were mixed. Different species within each genus responded differently 
to chlorpyrifos exposure. In general, exposure to chlorpyrifos was linked to dysbiosis. In a study 
looking at long-term late postnatal exposure to chlorpyrifos in mice, Perez-Fernandez et al. 
observed gut dysbiosis at both the genus and species levels of the microbiota (Perez-Fernandez 
2019). Table 3 summarizes the microbes that were affected by chlorpyrifos exposure and the 
systems they contribute to. 
There are 19 microbes that were found to have reduced abundance with the presence of 
chlorpyrifos. Eight of these microbes are associated, both negatively and positively, with obesity. 
Five are associated with diabetes, three are associated with neurological conditions, one is 
associated with pancreatitis,  and one is associated with immune system function. Nine are in the 
Firmicutes phylum, making them the most represented microbes experiencing reductions (Fang 
et al., 2018; Li et al., 2019; Yang et al., 2019; Zhao et al., 2016; Liang et al., 2019). There are 
four microbes represented from the Bacteroidetes phylum. Four of the microbes are pathogenic 
(​Hydrogenoanaerobacterium, Aerococcus, Brevundimonas, Oscillibacter​), nine are beneficial 
(​Pseudoflavonifractor, Anaerosporobacter, Olsenella, Alloprevotella, Ruminococcus, 
Clostridium_sensu_stricto_1, Paenalcaligenes, Bifidobacterium, ​and unspecified Bacteroidetes​), 
two are both pathogenic and beneficial (​Akkermansia muciniphila​ and Firmicutes in general), 




There were 21 microbes that were found to increase in abundance with the presence of 
chlorpyrifos. Ten are associated with obesity, seven are associated with diabetes, one is 
associated with the immune system function, eight are associated with neurological conditions, 
four is associated with digestion, and one is associated with pancreatitis. Firmicutes represent 
more than half of these microbes with thirteen microbes, while three Bacteroidetes were also 
found to be enriched. Twelve of the microbes are pathogenic (​Candidatus Arthromitus, 
Roseburia, Coprococcus, Blautia, Acinetobactor, Pseudomonas, Sutterlla, Anaeoplasma, 
Candidatus Saccharimonas, Clostridium clusters​, unspecified Proteobacteria and unspecified 
Verrucomicrobia), seven are beneficial (​Allobaculum, Alloprevotella, Enterococcus, 
Clostridium_sensu_stricto_1, Bacteroides fragilis, Ruminococcus, ​and unspecified 
Bacteroidetes) , three are both pathogenic and beneficial (​Bacteriodes, Lactobacillus,​ and 
unspecified Firmicutes) and six have functions that are not well understood (Staphylococcus, 
unspecified Aerobes, unspecified  Actinobacteria, unspecified Cyanobacteria, unspecified 
Enterobacteria, and unspecified Tenericutes). 
Table 2 summarizes the implicit impact of chlorpyrifos exposure on health conditions as 
it relates to the microbes. Neurological and mental health conditions as a category had no 
correlation between impact and the change in abundance of corresponding microbes, while all 
but Autism Spectrum disorder individually had insufficient data to determine the presence of a 
correlation. No studies found any influence on anxiety-related microbes ​L. rhamnosus​ and ​B. 
longum​ by chlorpyrifos. All other conditions have a negative phi coefficient, with the strongest 




Table 2  Chlorpyrifos Impact and Changes in Abundance  1
Condition +/Increase +/Decrease -/Increase -/Decrease Phi Coefficient 
Neurological/Mental 4 2 6 3 0.00 
Parkinson’s Disease 0 0 1 2 -- 
Autism Spectrum Disorder 2 1 5 2 -0.05 
Major Depressive Disorder 1 1 0 0 -- 
Multiple Sclerosis 0 0 0 1 -- 
Chronic Fatigue Syndrome 1 1 0 0 -- 
Multiple System Atrophy 0 0 1 0 -- 
Gastrointestinal Tract 3 3 1 0 -0.35 
Diabetes 2 2 4 0 -0.58 
Obesity 3 5 4 0 -0.60 
Immune System 0 1 1 0 -1.00 
Pancreatitis 2 1 2 0 -0.41 
TOTAL 18 17 25 8 -0.25 
 
1 +/- represents microbes with  positive (+) or negative (-) health impacts. For example, +/Increase 
represent microbes that have positive health impacts and experienced an increase in abundance with 




The impacts of chlorpyrifos exposure on gut microbiota and their associated health 
conditions are mixed.  The true role of these microbes and the mechanisms in which they operate 
are not well understood. Many studies lack the granularity needed to fully understand the 
nuances within genera and even phyla. For example, ​Bacteriodes ​are a relatively well studied 
genus of gut microbes and are negatively associated with glucose and lipid metabolism, obesity 
and diabetes, but positively associated with multiple system atrophy and autism spectrum 
disorder. It is unclear if this is characteristic of all members in this genus or if there are distinct 
roles at the species level.  
The phi coefficients observed in Table 2 imply that there may be a negative correlation 
between positive impacts and increased abundance associated with exposure to chlorpyrifos. The 
strongest relationships are observed with diabetes with a coefficient of -0.58, obesity with -0.60 
and the immune system with a -1.00, though it should be noted that there were only two immune 
system-related microbes affected. These negative phi coefficients align with the expectation that 
the introduction of a pesticide would correlate with a decrease in beneficial microbes and an 
increase in negative microbes. For diabetes, the beneficial microbes were equally found to 
increase and decrease in abundance, while pathogenic microbes were only found to increase in 
abundance. This would imply that chlorpyrifos’ influence on diabetes via the gut microbiome 
would more likely be through pathogenic means. Obesity shares a similar relationship, though 
the number of studies finding a reduction in beneficial microbes slightly outnumbers an increase 
in their abundance. It is expected that these two metabolic-related conditions have the strongest 
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correlation of those investigated as they are known to be critical in metabolic systems and this 
role is relatively better studied. There was also a moderate negative correlation for 
gastrointestinal related microbes, which is expected considering that microbes can influence 
inflammation and digestion.​The studies involving diet gives insight on the role that fat may play 
in reducing the impacts of chlorpyrifos. Liang et al. did not observe significant impacts of diet on 
microbiome changes from chlorpyrifos exposure, but Li et al. and Fang et al. did. They all found 
that the exposure increased risk of obesity and insulin insensitivity (Liang et al., 2019, Fang et 
al., 2018, Li et al., 2019). Joly Condette et al. found that ​perinatal exposure in rats was also 
linked to dysbiosis of intestinal microbes (Joly Condette et al., 2015). A low 
Firmicute:Bacteroidetes ratio is usually associated with weight loss in studies that investigate gut 
microbe relationships with obesity, and from this compilation, it seems like chlorpyrifos aids in 
that. ​This may be a​ result of limited studies that have looked at the microbes at a genus level. 
Importantly, ​the ratio is naturally dynamic, increasing as people grow into adulthood and will 
continue to change into later stages in life (Mariat et al., 2009).  
Overall, the neurological and mental health conditions seem to not have any correlative 
effects via the gut microbiome from chlorpyrifos exposure. Both beneficial and pathogenic 
microbes were found to increase in abundance two times more than those that were found to 
decrease.   There is a very weak negative correlation between the positive impact and increase in 
the abundance of microbes associated with Autism Spectrum Disorder. Surprisingly, no 
relationship was found with Parkinson’s disease despite its relatively strong association with gut 





The most pressing limitation of this rapid systematic review is the lack of depth 
information on the microbes. Although this is likely an exhaustive list of studies examining 
impacts of chlorpyrifos on the gut microbiome to date, this review lacks full coverage of all 
known microbes and their functions. There is a very limited number of studies investigating the 
relationship between chlorpyrifos exposure and gut microbe health in humans and thus did not 
provide significant insight. Instead, all of the reviewed literature are based on rat and mice 
studies so it is uncertain how accurately these interactions reflect the interactions in the human 
gut. There are also limited studies on the gut microbiome in general. This limitation most likely 
impacted the results observed in Table 2 and, thus, shroud the correlations in uncertainty. 
Importantly, these associations cannot determine causal relationships. The chlorpyrifos was also 
administered at varying degrees and stages of life for the animals. With changes in microbe 
profiles as mammals age, it may make it unclear if that may be a confounding factor. The gut 
microbe profile varied among rat and mice species, so when this work is translated to the human 
microbiome, it would be important to consider the variation in microbial profiles of different 
ethnicity and socioeconomic status. Eating trends are heavily influenced by culture and thus both 
exposures and health impacts will vary. 
 
CONCLUSION 
In conclusion, there is still a great deal of research on the gut microbiome needed to 
understand how it influences health outcomes. This review found that chlorpyrifos exposure may 
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be associated with negative impacts on the gut microbiome,  especially obesity, diabetes, and 
compromised immune response. Perinatal exposure in rats was also linked to dysbiosis of 
intestinal microbes. Further research resulting in primary data would be needed to substantiate 
the relationships. Even with a clear understanding of the relationship, further research needs to 
be conducted to determine if the microbes are a product of health outcomes or vice versa. 
Species level investigation would be critical in characterizing the true interactions of the gut. 
This information can be used to identify another possible component of nutrition that fuels health 
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Table 3 Microbe and Associated Health Conditions  
Phylum Genus Health Outcome Reference 
Actinobacteria Olsenella Diabetes, Obesity 
Fang et al 2018; Andoh et al 
2016 
​Actinobacteria Bifidobacterium Digestion, Brain 
Rajilic-Stojanovicet al.,2011 and 
Kerckhoffs et al.,2009; Grenham 
et al., 2011; Aizawa et al., 2016; 
Fung et. al., 2017 
Actinobacteria  Digestion 
Frank et al., 2007; Grenham et 
al., 2011 
​Actinobacteria Bifidobacterium longum Brain 
Bercik et al., 2011; Radisavljevic 
et al., 2019 
Actinobacteria Collinsella aerofaciens Digestion 




Brain Fang et al 2018 
Bacteroidetes Bacteroides fragilis Brain 
Hsiao et al., 2013; Radisavljevic 
et al., 2019 
Bacteroidetes  Digestion, Obesity 
Rajilic-Stojanovicet al., 2011; 
Grenham et al., 2011 
Bacteroidetes Alloprevotella Pancreatitis Fang et al 2018 




Bacteroidetes Prevotella Brain ?; Radisavljevic et al., 2019 
Euryarchaeota Methanobrevibacter Brain 





Joossens et al., 2011; Grenham et 
al., 2011; Balamurugan et al., 
2009 
Firmicutes Amphibacillus -- Fang et al 2018 
Firmicutes Trichococcus -- Fang et al 2018 
Firmicutes  Brain, Obesity Radisavljevic et al. 2019 
Firmicutes Lactobacillus Digestion, Brain 
Malinen et al., 2005; Grenham et 
al., 2011; Aizawa et al., 2016 
Firmicutes Clostridium clusters Brain 
Tomova et al., 2014; Fung et al., 
2017 
Firmicutes Candidatus Arthromitus Brain Fang et al 2018 
Firmicutes Hydrogenoanaerobacterium 
Brain, Diabetes, 
Obesity Fang et al 2018; Jung et al 2016 
Firmicutes Aerococcus Diabetes, Obesity Fang et al 2018 
Firmicutes Roseburia Diabetes, Obesity Fang et al 2018; Zhang 2013 
Firmicutes Veillonella Digestion 
Malinen et al., 2005 and Tana et 
al., 2010; Grenham et al., 2011 
Firmicutes Ruminococcus gnavus Digestion 




Firmicutes Ruminococcus torques Digestion 
Joossens et al., 2011; Grenham et 
al., 2011 
Firmicutes Oscillibacter Obesity Fang et al 2018; Galley 2014 
Firmicutes Coprococcus Obesity 
Fang et al 2018; Andoh et al 
2016 
Firmicutes Candidatus Saccharimonas Pancreatitis Fang et al 2018 
Firmicutes Enterococcus Brain 




1 Diabetes, Obesity Fang et al 2018 
Firmicutes Ruminococcus Digestion Fang et al 2018; Ze et al 2012 
Firmicutes Lactobacillus rhamnosus Brain 
Bravo et al., 2011; Radisavljevic 
et al. 2019 
Firmicutes Pseudoflavonifractor Obesity Fang et al 2018; Louis et al 2016 
Firmicutes Lachnospiraceae (family) Brain ?; Radisavljevic et al., 2019 
Firmicutes Faecalibacterium Brain 
Rajilic-Stojanovicet al.,2011; 
Grenham et al., 2011 
Firmicutes Allobaculum Pancreatitis Fang et al 2018 
Firmicutes Lactobacillus reuteri Immune, Obesity 
Athalye-Jape et al (2016); 
Million et al., 2011 
Firmicutes 
Lactobacillus 
casei/paracasei Obesity Million et al., 2013 
Firmicutes Lactobacillus plantarum Obesity Million et al., 2013 
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Firmicutes Clostridium difficile Diabetes, Obesity Goldenberg et al (2017) 
Firmicutes Blautia Diabetes Fang et al 2018 
Firmicutes Anaerosporobacter Immune Fang et al 2018 
Proteobacteria Betaproteobacteria Brain, Diabetes Larson et al., 2010 
Proteobacteria Desulfovibrio Brain 
Tomova et al., 2014; Fung et al., 
2017 
Proteobacteria Acinetobactor Diabetes, Obesity Fang et al 2018 
Proteobacteria Brevundimonas Diabetes, Obesity Fang et al 2018 
Proteobacteria Pseudomonas Diabetes, Obesity Fang et al 2018 
Proteobacteria  Digestion 
Frank et al., 2007; Grenham et 
al., 2011 
Proteobacteria Sutterlla Immune, Brain 
Fang et al 2018; Radisavljevic et 
al. 2019 
Proteobacteria Paenalcaligenes Obesity Li et al., 2019 
Tenericutes Anaeoplasma Diabetes, Obesity Fang et al 2018 
Verrucomicrobia Akkermansia Brain 
Jangi et al., 2016; Fung et al., 
2017 
Verrucomicrobia Akkermansia muciniphila Brain, Obesity 
Everard et al., 2013; 
Radisavljevic et al., 2019; Fang 
et al., 2019 





Table 4  Chlorpyrifos Impact on Gut Microbe Abundance 
0 = decrease, 1 = increase. Both may be indicated if multiple studies have contradicting findings. 






associated with obesity 
and diabetes p 0 Fang et al., 2018 
​Actinobacteria Bifidobacterium 
negatively associated 
with irritable bowel 
syndrome; negatively 
associated with major 
depressive disorder, 
autismi p 0 Reygner et al., 2016 
Bacteroidetes Bacteriodes 
negatively associated 
with glucose and lipid 
metabolism, obesity and 
diabetes; positively 
associated with multiple 




could restore gut barrier 




deficits in a maternal p 1 Joly-Condette et al., 2014 
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with irritable bowel 
syndrome p 1, 0 




with pancreatitis p 0,1 Fang et al., 2018 
Firmicutes Amphibacillus Relatively unknown -- 0 Fang et al., 2018 
Firmicutes Trichococcus Relatively unknown -- 0 Fang et al., 2018 
Firmicutes  
negatively associated 
with chronic fatigue and 
positively associated with 
obesity, autism b 0,1 




associated with irritable 
bowel syndrome; 
negatively associated 
with major depressive 
disorder, positively 




positively associated with 




positively associated with 
neurotoxicity and n 1 Fang et al 2018 
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positively associated with 
obesity and diabetes and 
Parkinsons n 0 Fang et al 2018 
Firmicutes Aerococcus 
associated with glucose 
and lipid metabolism, 
obesity and diabetes n 0 Fang et al., 2018 
Firmicutes Roseburia 
positively associated with 
obesity and diabetes; has 
been found to be 
negatively correlated 
with serum glucose n 1 Fang et al 2018 
Firmicutes Oscillibacter 
positively associated with 
obesity n 0 Li et al., 2019 
Firmicutes Coprococcus 
positively associated with 





with pancreatitis n 1 Fang et al 2018 
Firmicutes Enterococcus 
negatively associated 
with autism p 1 
Joly et al., 2012, 




associated with glucose 
and lipid metabolism, and 
diabetes; 




breaks down plant 





with obesity p 0 Fang et al 2018 
Firmicutes Allobaculum 
negatively associated 
with pancreatitis p 1 Fang et al 2018 
Firmicutes Blautia 
positively associated with 
progress in the 
development of diabetes n 1 Fang et al 2018 
Firmicutes Anaerosporobacter 
positively associated with 
acetylcholine for cell 
immunity p 0 Fang et al 2018 
Proteobacteria Acinetobactor 
associated with glucose 
and lipid metabolism, 
obesity and diabetes n 1 Fang et al 2018 
Proteobacteria Brevundimonas 
associated with glucose 
and lipid metabolism, 
obesity and diabetes n 0 Fang et al., 2018 
Proteobacteria Pseudomonas 
positively associated with 
glucose and lipid 
metabolism, obesity and 
diabetes n 1 Fang et al 2018 
Proteobacteria  
positively associated with 
inflammatory bowel 





with acetylcholine for 
cell immunity, positively 
associated with autism n 1 Fang et al 2018 
Proteobacteria Paenalcaligenes 
negative relationship with 
high fat diet p 0 Li et al., 2019 
Tenericutes Anaeoplasma 
associated with glucose 
and lipid metabolism, 








autism, and multiple 
sclerosis b 0 Guardia-Escote et al., 2019 
Verrucomicrobia  
positively associated with 
Parkinsons n 1 Liang et al., 2019 
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